Actionable news
0
All posts from Actionable news
Actionable news in INO: Inovio Pharmaceuticals, Inc.,

GeneOne Life Science and Inovio Pharmaceuticals’ MERS Vaccine Approved for First-in-Human Study

SEOUL, South Korea, Nov. 19, 2015 (GLOBE NEWSWIRE) -- GeneOne Life Science Inc. (KSE:011000) today announced that the U.S. Food and Drug Administration has cleared the first-in-human clinical study of its collaborative vaccine for MERS (Middle East Respiratory Syndrome). GeneOne Life Science and Inovio Pharmaceuticals (INO) are co-developing the vaccine and plan to initiate the first human trial of a MERS vaccine before the end of the year in partnership with the Walter Reed Army Institute of Research (WRAIR).

Earlier this month, GeneOne Life Science signed a joint clinical development agreement with WRAIR to advance the MERS vaccine...


More